VOLIBO M 0.3

1. Specifications
Product Name: Volibo® M 0.3
Generic Components: Voglibose IP (0.3 mg) and Metformin Hydrochloride IP (500 mg)
Form: Uncoated Tablet
Manufacturing License Number: 374/DR/Mfg/2013
Batch/Lot: 5243063
2. General Information
Brand: Volibo® M
Type: Anti-diabetic combination therapy
Food Preference: Typically taken with food to minimize gastrointestinal discomfort; follow your doctor’s specific instructions.
FSSAI Status: Not applicable (This is a pharmaceutical drug, not a food product).
Storage Conditions: Store at a temperature not exceeding 25°C, protected from light and moisture.
3. Product Details (Ingredients)
Each uncoated tablet contains:
Voglibose IP: 0.3 mg
Metformin Hydrochloride IP: 500 mg
Excipients: q.s. (quantity sufficient)
4. Directions for Use
Administration: Take this medication orally. Swallow the tablet whole with water. Do not crush or chew the tablet unless instructed otherwise.
Dosage: Use strictly as directed by your prescribing specialist. Do not alter the dose or discontinue use without consulting your physician.
5. Description
Volibo® M 0.3 is a prescription medication indicated for the management of Type 2 Diabetes Mellitus. It is a combination drug designed to assist in glycemic control:
Metformin Hydrochloride helps improve insulin sensitivity and decreases the amount of glucose produced by the liver.
Voglibose acts as an alpha-glucosidase inhibitor, which delays the breakdown and absorption of carbohydrates from the small intestine, helping to prevent significant post-meal blood sugar spikes.
6. Manufacturer Information
Manufactured by: Sun Pharma Laboratories Ltd.
Address: Vill. Kokjhar, Mirza Palashbari Road, P.O.: Palashbari, Dist. Kamrup, Assam-781128.
7. Marketed By
Marketed by: Sun Pharmaceutical Industries Ltd.